when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

MIFEPRISTONE · news · pharmadog

← back to MIFEPRISTONE

News mentioning MIFEPRISTONE

61 stories

May 13, 26Extreme heat is worsening faster for Black Americansstat

May 12, 26Males who discuss suicide seek help less often than females, report findsstat

May 12, 26FDA chief Marty Makary resigns from agency, ending tumultuous tenurebiopharma dive

May 12, 26Supreme Court extends mifepristone deadlinestat

May 11, 26Supreme Court temporarily extends women’s access to a widely used abortion pillstat

May 11, 26STAT+: Trump pivots on kratom derivative 7-OH, floating approval for some formsstat

May 11, 26STAT+: Pharmalittle: We’re reading about Medicare and Alzheimer’s drugs, estrogen patch shortages, and morestat

May 11, 26The connection between periods and mental healthstat

May 9, 26Experts wonder ‘Where is the CDC?’ as hantavirus outbreak unfoldsstat

May 8, 26Spain readies for evacuations as a hantavirus-hit cruise ship heads for the Canary Islandsstat

May 8, 26STAT+: Roche to buy PathAI for $750 millionstat

May 8, 26Trump reportedly plans to fire FDA Commissioner Makarystat

May 8, 26Former FDA leaders, pharma speak out on mifepristonestat

May 8, 26STAT+: Pharmalittle: We’re reading about an FDA gender rule change, its program for one-day inspections, and morestat

May 8, 26The aging scientific workforce collides with rising fabricating citations in medical journalsstat

May 7, 26Hospital shootings steadily increased since 2000stat

May 6, 26Why the FDA is authorizing fruit-flavored vapesstat

May 6, 26HHS tackles ‘overmedication’stat

May 5, 26What you need to know about hantavirus (don’t panic)stat

May 5, 26Opinion: The ‘brain drain’ narrative about health professionals misses half of the storystat

May 5, 26Opinion: The cruise ship hantavirus outbreak is a warning sign to the U.S.stat

May 4, 26Opinion: Mifepristone court ruling makes drug development riskier for everyonestat

May 4, 26Supreme Court restores mifepristone access by mailendpoints

May 4, 26Supreme Court restores access to abortion pill mifepristone through telehealth, mail, and pharmaciesstat

May 4, 26Researchers urge study of paternal deaths, though a new paper finds fatherhood is protectivestat

May 4, 26UCB to acquire maker of antibody treatments for autoimmune diseasesstat

May 4, 26What to know about hantavirus, the illness suspected in a cruise ship outbreakstat

May 4, 26STAT+: Pharmalittle: We’re reading about an abortion pill controversy, another UCB deal, and more newsstat

May 4, 26Federal court blocks mailing of mifepristonestat

May 4, 26Immigration changes are driving foreign researchers to leave the U.S. — or not come to begin withstat

← prevpage 2 of 3next →